tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NVCR Stock Latest News

NovoCure’s Pivotal Study on Optune® for Glioblastoma: A Market Game-Changer?
Company AnnouncementsNovoCure’s Pivotal Study on Optune® for Glioblastoma: A Market Game-Changer?
1d ago
NVCR
Novocure’s Earnings Call: Clinical Successes & Cautious Optimism
PremiumCompany Announcements
Novocure’s Earnings Call: Clinical Successes & Cautious Optimism
11d ago
NVCR
Positive Outlook for NovoCure: Strong Financial Performance and Promising Pipeline Developments
PremiumRatings
Positive Outlook for NovoCure: Strong Financial Performance and Promising Pipeline Developments
11d ago
NVCR
Novocure Ltd. Reports Q2 2025 Financial Results
PremiumCompany Announcements
Novocure Ltd. Reports Q2 2025 Financial Results
15d ago
NVCR
Wells Fargo downgrades Novocure after ‘disappointing’ Q2
PremiumThe Fly
Wells Fargo downgrades Novocure after ‘disappointing’ Q2
15d ago
NVCR
Novocure downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe FlyNovocure downgraded to Equal Weight from Overweight at Wells Fargo
15d ago
NVCR
NovoCure’s Strategic Growth and Market Expansion Drive Buy Rating
Premium
Ratings
NovoCure’s Strategic Growth and Market Expansion Drive Buy Rating
15d ago
NVCR
Novocure reports Q2 EPS (36c), consensus (39c)
Premium
The Fly
Novocure reports Q2 EPS (36c), consensus (39c)
15d ago
NVCR
NVCR Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NVCR Earnings this Week: How Will it Perform?
17d ago
NVCR
Ladenburg starts Novocure with a Buy, sees ‘path to profitability’
PremiumThe Fly
Ladenburg starts Novocure with a Buy, sees ‘path to profitability’
1M ago
NVCR
Novocure initiated with a Buy at Ladenburg
PremiumThe Fly
Novocure initiated with a Buy at Ladenburg
1M ago
NVCR
Promising Phase 3 Results for NovoCure’s TTFields Therapy in Pancreatic Cancer
PremiumRatings
Promising Phase 3 Results for NovoCure’s TTFields Therapy in Pancreatic Cancer
1M ago
NVCR
Novocure to present final secondary endpoint results from PANOVA-3 trial
PremiumThe FlyNovocure to present final secondary endpoint results from PANOVA-3 trial
1M ago
NVCR
Novocure management to meet with Piper Sandler
Premium
The Fly
Novocure management to meet with Piper Sandler
2M ago
NVCR
NovoCure Appoints New President at Annual Meeting
Premium
Company Announcements
NovoCure Appoints New President at Annual Meeting
2M ago
8K
NVCR
Novocure data support pancreatic cancer approval, says Wells Fargo
PremiumThe Fly
Novocure data support pancreatic cancer approval, says Wells Fargo
2M ago
NVCR
NovoCure Announces Positive Phase 3 Trial Results
PremiumCompany Announcements
NovoCure Announces Positive Phase 3 Trial Results
2M ago
8K
NVCR
Positive Buy Rating for NovoCure Driven by Promising PANOVA-3 Trial Results in Pancreatic Cancer Treatment
PremiumRatings
Positive Buy Rating for NovoCure Driven by Promising PANOVA-3 Trial Results in Pancreatic Cancer Treatment
2M ago
NVCR
Positive Outlook for NovoCure Amid Promising PANOVA-3 Trial Results and Anticipated FDA Approval
PremiumRatings
Positive Outlook for NovoCure Amid Promising PANOVA-3 Trial Results and Anticipated FDA Approval
2M ago
NVCR
Novocure announces results from Phase 3 PANOVA-3 trial
PremiumThe FlyNovocure announces results from Phase 3 PANOVA-3 trial
2M ago
NVCR
NovoCure’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
Premium
Ratings
NovoCure’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
3M ago
NVCR
Novocure’s Q1 2025: Revenue Growth and Strategic Advances
Premium
Company Announcements
Novocure’s Q1 2025: Revenue Growth and Strategic Advances
4M ago
NVCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >